EPA:ALMIB - FR0011051598 - Common Stock
The current stock price of ALMIB.PA is 0.87 EUR. In the past month the price increased by 4.07%. In the past year, price increased by 62.92%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
GIN.DE | GIVAUDAN-REG | 27.55 | 33.86B | ||
SIKA.DE | SIKA AG-REG | 24.09 | 31.40B | ||
6D81.DE | DUPONT DE NEMOURS INC | 16.91 | 27.11B | ||
DSFIR.AS | DSM-FIRMENICH AG | 87.29 | 21.80B | ||
BRG.OL | BORREGAARD ASA | 23.48 | 20.85B | ||
ELK.OL | ELKEM ASA | N/A | 16.00B | ||
1IFF.MI | INTL FLAVORS & FRAGRANCES | 15.42 | 14.78B | ||
SY1.DE | SYMRISE AG | 22.52 | 11.42B | ||
1COV.DE | COVESTRO AG | N/A | 10.45B | ||
AKZA.AS | AKZO NOBEL N.V. | 15.91 | 10.26B | ||
AMC.DE | ALBEMARLE CORP | N/A | 8.02B | ||
SYENS.BR | SYENSQO SA | 20.09 | 7.79B |
Amoéba SA.is a lyonnaise greentech company based on chassieu whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. The company is headquartered in Chassieu, Auvergne-Rhone-Alpes and currently employs 18 full-time employees. The company went IPO on 2015-07-10. The firm specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The firm's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The firm is engaged in various technical, commercial, industrial and investment partnerships.
AMOEBA SAS
38 avenue des Freres Montgolfier
Chassieu AUVERGNE-RHONE-ALPES FR
Employees: 20
Phone: 33426691600
The current stock price of ALMIB.PA is 0.87 EUR. The price decreased by -1.36% in the last trading session.
The exchange symbol of AMOEBA SAS is ALMIB and it is listed on the Euronext Paris - Matif exchange.
ALMIB.PA stock is listed on the Euronext Paris - Matif exchange.
11 analysts have analysed ALMIB.PA and the average price target is 1.53 EUR. This implies a price increase of 75.86% is expected in the next year compared to the current price of 0.87. Check the AMOEBA SAS stock analysts ratings, price target forecast and up-and down grades for more detailed information.
AMOEBA SAS (ALMIB.PA) has a market capitalization of 59.96M EUR. This makes ALMIB.PA a Micro Cap stock.
AMOEBA SAS (ALMIB.PA) currently has 20 employees.
AMOEBA SAS (ALMIB.PA) has a support level at 0.83 and a resistance level at 0.91. Check the full technical report for a detailed analysis of ALMIB.PA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALMIB.PA does not pay a dividend.
AMOEBA SAS (ALMIB.PA) will report earnings on 2025-10-01.
AMOEBA SAS (ALMIB.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.13).
ChartMill assigns a technical rating of 4 / 10 to ALMIB.PA. When comparing the yearly performance of all stocks, ALMIB.PA is one of the better performing stocks in the market, outperforming 88.09% of all stocks.
Over the last trailing twelve months ALMIB.PA reported a non-GAAP Earnings per Share(EPS) of -0.13. The EPS increased by 54.2% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -116.64% | ||
ROE | N/A | ||
Debt/Equity | N/A |
11 analysts have analysed ALMIB.PA and the average price target is 1.53 EUR. This implies a price increase of 75.86% is expected in the next year compared to the current price of 0.87.